Imaging of cholinergic terminals using the radiotracer [18F](+)-4- fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in nonhuman primates

Synapse

Volumn 25, Issue 4, 1997, Pages 368-380

  Mach, Robert H ^a   Voytko, Mary Lou ^a   Ehrenkaufer, Richard L E ^a   Nader, Michael A ^a   Tobin, Joseph R ^a   Efange, Simon M N ^b   Parsons, Stanley M ^c   Gage, H Donald ^a   Smith, Cynthia R ^a   Morton, Thomas E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cholinergic terminals; positron emission tomography; rhesus monkey; vesamicol receptor

Indexed keywords

4 FLUOROBENZYLTROZAMICOL; ACETYLCHOLINE; FLUORINE 18; TRACER; UNCLASSIFIED DRUG; VESAMICOL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHOLINERGIC NERVE; CONTROLLED STUDY; ELECTRIC ORGAN; ISOTOPE LABELING; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; RHESUS MONKEY; STEREOISOMERISM;

ANIMALS; BASAL GANGLIA; BRAIN; CARRIER PROTEINS; CEREBELLUM; FLUORINE RADIOISOTOPES; FLUOROBENZENES; FRONTAL LOBE; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE TRANSPORT PROTEINS; NEUROMUSCULAR DEPOLARIZING AGENTS; OCCIPITAL LOBE; ORGAN SPECIFICITY; PIPERIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; STEREOISOMERISM; SYNAPTIC VESICLES; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0031002932     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199704)25:4<368::AID-SYN8>3.0.CO;2-8     Document Type: Article

References (67)

1. 3H]vesamicol binding in brain: Autoradiographic distribution, pharmacology, and effects of cholinergic lesions. Synapse, 2:486-493.
2. Arai, R., Karasawa, N., Geffard, M., and Nagatsu, I. (1995) L-DOPA is converted in serotonergic fibers of the striatum of the rat: A double-labelingimmunofluorescence study. Neurosci. Lett., 195:195-198.
3. Aubert, I., Araujo, D.M., Cecyre, D., Robitaille, Y., Gauthier, S., and Quirion, R. (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem., 58:529-541.
4. Bartus, R.T., and Johnson, H.R. (1976) Short-term memory in the rhesus monkey: Disruption from the anti-cholinergic scopolamine. Pharmacol. Biochem. Behav., 5:39-46.
5. Bowen, D.M., Smith, C.B., White, P., and Davison, A.N. (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain, 99:459-496.
6. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248-254.
7. 50) of an enzymatic reaction. Biochem. Pharmacol., 22:3099-3108.
8. A receptors in Alzheimer's disease: A quantitative autoradiographic study. Neurology, 37:1454-1459.
9. 11C]tetrabenazine. Synapse 14:128-131.
10. 11C]methoxy derivative of γ-dihydrotetrabenazine for PET imaging of monoaminergic nerve terminals. J. Labeled Comp. Radiopharm. 32:257-259.
11. Davies, P., and Maloney, A.J.F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2:1403.
12. Decker, M.W. (1987) The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res. Rev., 12:424-438.
13. Ding, Y.-S., Fowler, J.S., Volkow, N.D., Logan, J., Gatley, S.J., and Sugano, Y. (1995) Carbon-11-d-threo-Methylphenidate binding to dopamine transporter in baboon brain. J. Nucl. Med., 36:2298-2305.
14. Drachman, D.A. (1977) Memory and cognitive function in man: Does the cholinergic system have a specific role? Neurology, 27:783-790.
15. Drachman, D.A., and Leavitt, J. (1974) Human memory and the cholinergic system. A relationship to aging? Arch. Neurol., 30:113-121.
16. 125I]MIBT): Potential radioligand for mapping central cholinergic innervation. J. Med. Chem., 36:1745-1760.
17. 18F]FBT): Molecular decomposition-reconstitution approach to vesamicol receptor radioligands for positron emission tomography. Appl. Radiat. Isot 45:465-472.
18. Efange, S.M.N., Mach, R.H., Smith, C.R., Khare, A.B., Foulon, C., Akella, S.K., Childers, S.R., and Parsons, S.M. (1995a) Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor. Biochem. Pharmacol. 49:791-797.
19. 125I]MIBT binding in human temporal cortex reveals cholinergic hypofunction in Alzheimer's disease. J. Labelled Comp. Radiopharm., 37:376-377 (abstract).
20. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse, 16:93-103.
21. 18F]N-methylspiroperidol in baboon using PET. Nucl. Med. Biol., 13:281-284.
22. 11C-labeled suicide inactivators and PET. Science, 235:481-485.
23. Geula, C., and Mesulam, M.-M. (1994) Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In: Alzheimer Disease. R.D. Terry, R. Katzman, and K.L. Bick, eds. Raven Press, New York, pp. 263-291.
24. Gozlan, H., Daval, G., Verge, D., Spampinato, U., Fattaccini, C.M., Gallissot, M.C., El Mestikawy, S., and Hamon, M. (1990) Aging Associated Changes in Serotonergic and Dopaminergic Pre-and Postsynaptic Neurochemical Markers in the Rat Brain. Neurobiol. Aging 11:437-449.
25. 18F]fluoro-DOPA in human positron emission tomographic studies. J. Cereb. Blood Flow Metab., 11:898-913.
26. 2/acetylcholine interactions: PET studies of the vesamicol receptor. Neuroreport, 4:1311-1314.
27. Kilbourn, M.R. (1995) PET radioligands for vesicular neurotransmitter transporters. Med. Chem. Res., 5:113-126.
28. 3H]vesamicol binding in human brain cholinergic deficiency disorders. Neurosci. Lett., 117: 347-352.
29. Kuhl, D.E., Koeppe, R.A., Fessier, J.A., Minoshima, S., Ackermann, R.J., Carey, J.E., Gildersleeve, D.L., Frey, K.A., and Wieland, D.M. (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J. Nucl. Med., 35:405-410.
30. Lassen, N.A. (1992) Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. J. Cereb. Blood Flow Metab., 12:709-716.
31. Lehericy, S., Hirsch, E.C., Cervera, P., Hersh, L.B., Hauw, J.-J., Ruberg, M., and Agid, Y. (1989) Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A., 86:8580-8584.
32. Levin, E.D., McGurk, S.R., Rose, J.E., and Butcher, L.L. (1990) Cholinergic-dopaminergic interactions in cognitive performance. Behav. Neural Biol., 54:271-299.
33. 2 receptor-based imaging agents. Nucl. Med. Biol. 20:777-794.
34. 18F]fluorobenzyl iodide. J. Labelled Comp. Radiopharm., 35:157-159.
35. 2 receptors. Life Sci., 57:PL 57-62.
36. 2 receptors: In vitro binding studies and positron emission tomography. Synapse, 24:322-333.
37. 2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science, 228:1115-1117.
38. 18F]fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons. J. Labelled Comp. Radiopharm., 33:583-591.
39. Namba, H., Irie, T., Fukushi, K., and Iyo, M. (1994) In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog. Brain Res., 667:278-282.
40. Parsons, S.M., and Rogers, G. (1993) In vivo diagnostics for Alzheimer's disease based on the acetylcholine transporter. Ann. Reports Med. Chem., 28:247-255.
41. Parsons, S.M., Prior, C., and Marshall, I.G. (1993) Acetylcholine transport, storage, and release. Int. Rev. Neurobiol., 35:279-390.
42. 3H]hemicholinium-3 binding sites in human brain. Brain Res., 505:306-310.
43. Pearson, R.C.A., Sofroniew, M.V., Cuello, A.C., Powell, T.P.S., Eckenstein, F., Esiri, M.M., and Wilcock, G.K. (1983) Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res., 289:375-379.
44. Pelizzari, C.A., Chen, G.T.Y., Spelbring, D.R., Weichselbaum, R.R., and Chen, C.-T. (1989) Accurate three-dimensional registration of CT, PET, and MRI images of the brain. J. Comput. Assist. Tomogr., 13:20-26.
45. Perry, E.K., Perry, R.H., Smith, C.J., Purohit, D., Bonham, J., Dick, D.J., Candy, J.M., Edwardson, J.A., and Fairbairn, A. (1986) Cholinergic receptors in cognitive disorder. Can. J. Neurosci., 13:521-527.
46. Perry, R.H., Candy, J.M., Perry, E.K., Irving, D., Blessed, G., Fairbairn, A.F., and Tomlinson, B.E. (1982) Extensive loss of choline acetyltransferase is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett., 33:311-315.
47. Quirion, R. (1987) Characterization and autoradiographic distribution of hemicholium-3 high-affinity choline uptake sites in mammalian brain. Synapse, 1:293-303.
48. Redies, C., Diksic, M., Collier, B., Gjedde, A., Thompson, C.J., Gauthier, S., and Feindel, W.H. (1988) Influx of a choline analog to dog brain measured by positron emission tomography. Synapse, 2:406-411.
49. Reinikainen, K.J., Paljarvi, L., Huuskonen, M., Soininen, H., Laakso, M., and Riekkinen, P.J. (1988) A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J. Neurol. Sci., 84:101-116.
50. Reisine, T.D., Yamamura, H.I., Bird, E.D., Spokes, E., and Enna, S.J. (1978) Pre-and postsynaptic neurochemical alterations in Alzheimer's disease. Brain Res., 159:477-481.
51. 2 receptors in senile dementia of the Alzheimer type. Neurosci. Lett., 44:47-51.
52. 3H-hemicholinium-3. J. Neural. Trans. Park. Dis. Dement. Sect., 8:161-169.
53. Rogers, G.A., Parsons, S.M., Anderson, D.C., Nilsson, B.A., Bahr, W.D., Kornreich, R., Kaufman, R., Jacobs, R.S., and Kirtman, B. (1989) Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J. Med. Chem., 32:1217-1230.
54. Rogers, G.A., Kornreich, W.D., Hand, K., and Parsons, S.M. (1993) Kinetic and equilibrium characterization of vesamicol ligand complexes with picomolar dissociation constants. Mol. Pharmacol., 44:633-641.
55. Rossor, M., and Mountjoy, C.Q. (1986) Post-mortem neurochemical changes in Alzheimer's disease compared with normal ageing. Can. J. Neurol. Sci., 13:499-502.
56. 3H] vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience, 35:327-333.
57. Rupniak, N.M.J., Samson, N.A., Steventon, M.J., and Iversen, S.D. (1991) Induction of cognitive impairment by scopolamine and non-cholinergic agents in rhesus monkeys. Life Sci., 48:893-899.
58. Sanders-Bush, E., and Mayer, S.E. (1996) 5-hydroxytryptamine (serotonin) receptor agonists and antagonists. In: Goodman & Gilman's Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman and L.E. Limbird, eds. McGraw-Hill, New York, pp. 249-263.
59. Seeman, P., Bzowei, N.H., Guan, H.-G., Bergeron, C., Becker, L.E., Reynolds, G.P., Bird, E.D., Riederer, P., Jellinger, K., Wantanabe, S., and Tourtellotte, W.W. (1987) Human brain dopamine receptors in children and aging adults. Synapse, 1:399-404.
60. Suehiro, M., Musachio, J.L., Dannals, R.F., Matthews, W.B., Ravert, H.T., Scheffel, U., and Wagner, H.N., Jr. (1995) An improved method for the synthesis of radiolabeled McN5652 via thioester precursors. Nucl. Med. Biol., 22:543-545.
61. Sugaya, K., Giacobini, E., and Chiappinelli, V.A. (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease. J. Neurosci. Res., 27:349-359.
62. Tavitian, B., Pappata, S., Planas, A.M., Jobert, A., Bonnot-Lours, S., Crouzel, C., and DiGiamberardino, L. (1993) In vivo visualization of acetylcholinesterase with positron emission tomography. Neuroreport, 4:535-538.
63. Thibaut, F., Faucheux, B.A., Marquez, J., Villares, J., Menard, J.F., Agid, Y., and Hirsch, B.C. (1995) Regional distribution of mono-amine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: A postmortem study using tritiated tetrabenazine. Brain Res., 692:233-243.
64. A, muscatinic, and β adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease. J. Neurochem., 57:282-290.
65. Varoqui, H., Diebler, M.-F., Meunier, F.-M., Rand, J.B., Usdin, T.B., Bonner, T.I., Eiden, L.E., and Erickson, J.D. (1994) Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. FEBS Lett., 342:97-102.
66. Widen, L., Eriksson, L., Ingvar, M., Parsons, S.M., Rogers, G.A., and Stone-Elander, S. (1992) Positron emission tomographic studies of central cholinergic nerve terminals. Neurosci. Lett., 136:1-4.
67. 11C]WIN 35,428. Synapse, 15:130-142.